ANRG -- Anergen -- new CEO big chance ? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ANRG -- Anergen -- new CEO big chance ?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Harmon who wrote (112)	12/14/1998 8:25:00 AM
From: WWS	Read Replies (3) of 123

Steve, based on today's news it appears that CRXA is grabbing ANRG before CIST was able to. It appears that they're getting ANRG for a bit less than 50 cents per share--not a bad price for CRXA to pay when you consider that ANRG shares sold for over $1/share for most of the year, until October 19 when its lukewarm results were announced for its phase I trials of tx for Multiple Sclerosis. Of course, I understand why existing shareholders might not be too happy with the deal, except that they'll be converting into shares of CRXA, which appears to be a pretty good growth company with lots of prospective products and good partnering agreements.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next